Taken together, the additional molecular testing of BRAF, NRAS, and TERT promoter mutations not only enabled the identification of thyroid malignancies in FNAB cytology but also allowed the prediction of the aggressive characteristics of thyroid cancer. The gene discussed is BRAF; the disease is thyroid gland carcinoma.